4

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: December 4, 2020
Period of Report: December 2, 2020
Accession Number: 0001076809-20-000291

View Document ↗ View on SEC.gov ↗